Epinephrine Market Size

  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Epinephrine Market Size

Epinephrine Market size was over USD 1.25 billion in 2024 and is likely to exceed USD 5.77 billion by the end of 2037, witnessing over 12.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of epinephrine is evaluated at USD 1.37 billion.

The growth of the market can be attributed to the worldwide growing prevalence of several allergic reactions, along with the surge in neurological disorders. It is observed that every year, around 6 million people worldwide die from neurological disorders. In addition to this, the rising proportion of individuals who are prone to several allergies is another major factor that is estimated to boost the market growth throughout the forecast period.

In addition to these, factors that are believed to fuel the market growth of epinephrine include the upsurge in food allergy stances throughout the world. For instance, in the United States, approximately 33 million individuals are affected by food allergies. Furthermore, epinephrine is used as the first line of treatment to help reverse the effects of anaphylaxis. Individuals suffering from anaphylactic shock frequently use auto-injectors, as they are easy administer by non-medical personnel. Therefore, the rising occurrence of anaphylaxis cases is another significant factor that is estimated to fuel the growth of the market over the forecast period. For instance, anaphylaxis, a severe allergic reaction to food, is thought to cause nearly 91,000 emergency room visits annually in the United States.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of epinephrine is evaluated at USD 1.37 billion.

The epinephrine market size was over USD 1.25 billion in 2024 and is likely to exceed USD 5.77 billion by the end of 2037, witnessing over 12.3% CAGR during the forecast period i.e., between 2025-2037. Upsurge in chronic respiratory disorders, growing occurrence of several types of allergic reactions, escalation in cardiac arrests will drive the market growth.

North America is predicted to account for largest industry share by 2037, attributed to escalating count of patients suffering from respiratory diseases such as asthma, coupled with rapidly expanding population in the region.

The major players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample